動脈硬化
Online ISSN : 2185-8284
Print ISSN : 0386-2682
ISSN-L : 0386-2682
腸内細菌関連製剤
河合 康雄矢沢 一良下橋 博隆石原 一興末柄 信夫白井 徹郎北村 蓉子北見 久仁男藤本 彰遠藤 素彦高橋 健一葛谷 文男磯田 政恵大隅 正子
著者情報
ジャーナル オープンアクセス

1985 年 13 巻 2 号 p. 241-249

詳細
抄録
Several strains were screened from thousands of streptococcal strains isolated from the feces of healthy humans, and were found to have activities to reduce the levels of the serum cholesterol and triglyceride in rats and rabbits. Of the strains, Streptococcus faecalis AD1001 has strong hypocholesterolemic and hypotriglyceridemic activities in rats and rabbits, and an activity to cure atherosclerosis in rabbits. These effects are observed in the oral administration of the viable and heattreated dead cells, indicating that there are bacterial substances which reduce the cholesterol and triglyceride levels. It was revealed that the bacterial substances are protein and polysaccharide, respectively. The streptococci used in the present experiments were thought to be safe for the oral administration. The epidemiological study showed a negative co-relation between the population level of the fecal streptococci and the serum cholesterol level in hyperlipidemic patients.
著者関連情報
© 一般社団法人 日本動脈硬化学会

This article is licensed under a Creative Commons [Attribution-NonCommercial-ShareAlike 4.0 International] license.
https://creativecommons.org/licenses/by-nc-sa/4.0/
次の記事
feedback
Top